182 related articles for article (PubMed ID: 30275801)
1. Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments.
Li W; Xiao X; Li X; Xu Y; Ma L; Guo L; Yan C; Wu Y
Contrast Media Mol Imaging; 2018; 2018():9169072. PubMed ID: 30275801
[TBL] [Abstract][Full Text] [Related]
2. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
3. A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma.
Zhao M; Liu Z; Dong L; Zhou H; Yang S; Wu W; Lin J
Int J Nanomedicine; 2018; 13():4433-4443. PubMed ID: 30122918
[TBL] [Abstract][Full Text] [Related]
4. Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma.
Li YW; Chen ZG; Zhao ZS; Li HL; Wang JC; Zhang ZM
World J Gastroenterol; 2015 Apr; 21(14):4275-83. PubMed ID: 25892879
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinoma.
Li Y; Chen Z; Li F; Wang J; Zhang Z
Int J Nanomedicine; 2012; 7():4593-611. PubMed ID: 22956868
[TBL] [Abstract][Full Text] [Related]
6. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.
Wang Z; Han YJ; Huang S; Wang M; Zhou WL; Li HS; Wang QS; Wu HB
Amino Acids; 2018 Feb; 50(2):309-320. PubMed ID: 29204748
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection.
Qin Z; Wang J; Wang Y; Wang G; Wang X; Zhou Z; Liu G; Gao S; Zhu L
Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27862961
[TBL] [Abstract][Full Text] [Related]
8. Specific detection of CD133-positive tumor cells with iron oxide nanoparticles labeling using noninvasive molecular magnetic resonance imaging.
Chen YW; Liou GG; Pan HB; Tseng HH; Hung YT; Chou CP
Int J Nanomedicine; 2015; 10():6997-7018. PubMed ID: 26635474
[TBL] [Abstract][Full Text] [Related]
9. Ultrasmall superparamagnetic nanoparticles targeting E-selectin: synthesis and effects in mice in vitro and in vivo.
Liu L; Liu L; Li Y; Huang X; Gu D; Wei B; Su D; Jin G
Int J Nanomedicine; 2019; 14():4517-4528. PubMed ID: 31354271
[No Abstract] [Full Text] [Related]
10. Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles.
Guo Q; Liu Y; Xu K; Ren K; Sun W
Int J Nanomedicine; 2013; 8():2273-84. PubMed ID: 23818783
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol-coated ultrasmall superparamagnetic iron oxide nanoparticles-coupled sialyl Lewis X nanotheranostic platform for nasopharyngeal carcinoma imaging and photothermal therapy.
Liu Q; Liu L; Mo C; Zhou X; Chen D; He Y; He H; Kang W; Zhao Y; Jin G
J Nanobiotechnology; 2021 Jun; 19(1):171. PubMed ID: 34103070
[TBL] [Abstract][Full Text] [Related]
12. Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis.
Yan C; Wu Y; Feng J; Chen W; Liu X; Hao P; Yang R; Zhang J; Lin B; Xu Y; Liu R
Int J Nanomedicine; 2013; 8():245-55. PubMed ID: 23345972
[TBL] [Abstract][Full Text] [Related]
13. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.
Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K
Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341
[TBL] [Abstract][Full Text] [Related]
14. Targeted Molecular Magnetic Resonance Imaging Detects Brown Adipose Tissue with Ultrasmall Superparamagnetic Iron Oxide.
Hu Q; Chen X; Liu J; Di W; Lv S; Tang L; Ding G
Biomed Res Int; 2018; 2018():3619548. PubMed ID: 30406134
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced susceptibility weighted imaging with ultrasmall superparamagnetic iron oxide improves the detection of tumor vascularity in a hepatocellular carcinoma nude mouse model.
Yang SH; Lin J; Lu F; Dai YY; Han ZH; Fu CX; Hu FL; Gu HC
J Magn Reson Imaging; 2016 Aug; 44(2):288-95. PubMed ID: 26808392
[TBL] [Abstract][Full Text] [Related]
16. Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles.
Park JO; Stephen Z; Sun C; Veiseh O; Kievit FM; Fang C; Leung M; Mok H; Zhang M
Mol Imaging; 2011 Feb; 10(1):69-77. PubMed ID: 21303616
[TBL] [Abstract][Full Text] [Related]
17. Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection.
Kou G; Wang S; Cheng C; Gao J; Li B; Wang H; Qian W; Hou S; Zhang D; Dai J; Gu H; Guo Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):192-7. PubMed ID: 18621023
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of tumor angiogenesis using dual-targeting RGD10-NGR9 ultrasmall superparamagnetic iron oxide nanoparticles.
Wu T; Ding X; Su B; Soodeen-Lalloo AK; Zhang L; Shi JY
Clin Transl Oncol; 2018 May; 20(5):599-606. PubMed ID: 28956266
[TBL] [Abstract][Full Text] [Related]
19. Ultrasmall Paramagnetic Iron Oxide Nanoprobe Targeting Epidermal Growth Factor Receptor for In Vivo Magnetic Resonance Imaging of Hepatocellular Carcinoma.
Chen Y; Zhou Q; Li X; Wang F; Heist K; Kuick R; Owens SR; Wang TD
Bioconjug Chem; 2017 Nov; 28(11):2794-2803. PubMed ID: 28972742
[TBL] [Abstract][Full Text] [Related]
20. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
